English
Русский
简体中文
Português (Brasil)
Kazakh
Eco-vector
Pharmateca
ISSN 2073-4034 (Print) ISSN 2414-9128 (Online)
Menu     Archives
  • Home
  • About the Journal
    • Editorial Policies
    • Author Guidelines
    • About the Journal
  • Issues
    • Search
    • Current
    • Retracted articles
    • Archives
  • Contact
  • Subscriptions
  • Editorial Board
  • All Journals
User
Forgot password? Register
Notifications
  • View
  • Subscribe
Subscription Login to verify subscription
Search
Browse
  • By Issue
  • By Author
  • By Title
  • Other Journals
  • Categories
Keywords COVID-19 Helicobacter pylori arterial hypertension atopic dermatitis breast cancer bronchial asthma chemotherapy children chronic obstructive pulmonary disease diabetes mellitus insulin resistance metabolic syndrome non-steroidal anti-inflammatory drugs obesity osteoporosis pregnancy probiotics stroke treatment type 2 diabetes mellitus vitamin D
×
User
Forgot password? Register
Notifications
  • View
  • Subscribe
Subscription Login to verify subscription
Search
Browse
  • By Issue
  • By Author
  • By Title
  • Other Journals
  • Categories
Keywords COVID-19 Helicobacter pylori arterial hypertension atopic dermatitis breast cancer bronchial asthma chemotherapy children chronic obstructive pulmonary disease diabetes mellitus insulin resistance metabolic syndrome non-steroidal anti-inflammatory drugs obesity osteoporosis pregnancy probiotics stroke treatment type 2 diabetes mellitus vitamin D
Home > Search > Author Details

Author Details

Бурашникова, И. С

Issue Section Title File
No 20 (2017) Articles EFFECT OF BROMODIHYDROCHLOROPHENYLBENZODIAZEPINE ON EXTRAPYRAMIDAL DISORDERS RESULTING FROM ANTIPSYCHOTIC THERAPY OF PARANOID SCHIZOPHRENIA
Vol 27, No 13 (2020) Articles Drug therapy for asymp -tomatic carriers of SARS-CoV-2
Vol 28, No 1 (2021) Articles The possibility and prospects of using cytostatics in patients with COVID-19 on the example of cyclophosphamide
Vol 28, No 8 (2021) Articles The rationale for re-administration of genetically engineered biological drugs in patients with COVID-19
Vol 28, No 8 (2021) Articles The rationale for the combined use of genetically engineered biological drugs in patients with COVID-19
Vol 28, No 12 (2021) Articles Possibility and prospects for the use of recombinant neutralizing monoclonal antibodies (bamlanivimab+etesevimab, sotrovimab) in patients with COVID-19
 

 

Developed by ECO-VECTOR

 

Powered by EVESYST

TOP